These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9040906

  • 1. How to ensure fetal safety when mothers use isotretinoin (Accutane).
    Koren G, Pastuszak A.
    Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
    [No Abstract] [Full Text] [Related]

  • 2. Isotretinoin prescribing: finding a balance between benefit and risk.
    Stern RS.
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
    [No Abstract] [Full Text] [Related]

  • 3. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA, Paulozzi LJ, Erickson JD.
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [Abstract] [Full Text] [Related]

  • 4. Family physicians and accutane.
    Van Durme DJ.
    Am Fam Physician; 2000 Oct 15; 62(8):1772, 1774, 1777. PubMed ID: 11057835
    [No Abstract] [Full Text] [Related]

  • 5. The power of Accutane. The benefits and risks of a breakthrough acne drug.
    Meadows M.
    FDA Consum; 2001 Oct 15; 35(2):18-23. PubMed ID: 11444244
    [No Abstract] [Full Text] [Related]

  • 6. Side effects of acne therapy and their management.
    Miller RA.
    J Cutan Med Surg; 1998 May 15; 2 Suppl 3():14-8. PubMed ID: 9873118
    [No Abstract] [Full Text] [Related]

  • 7. Is topical tretinoin safe during the first trimester?
    Shapiro L, Pastuszak A, Curto G, Koren G.
    Can Fam Physician; 1998 Mar 15; 44():495-8. PubMed ID: 9559187
    [Abstract] [Full Text] [Related]

  • 8. Menstrual irregularity during isotretinoin treatment.
    Kwon HJ, Lee JY, Cho BK, Park HJ.
    J Eur Acad Dermatol Venereol; 2007 Apr 15; 21(4):562-3. PubMed ID: 17374003
    [No Abstract] [Full Text] [Related]

  • 9. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Jan 21; 49(2):28-31. PubMed ID: 10680601
    [Abstract] [Full Text] [Related]

  • 10. [Isotretinoin embryopathy. Report of one case].
    Troncoso Sch M, Rojas H C, Bravo C E.
    Rev Med Chil; 2008 Jun 21; 136(6):763-6. PubMed ID: 18769834
    [Abstract] [Full Text] [Related]

  • 11. Safety of Accutane with possible depression.
    Citrome L.
    Postgrad Med; 1998 Oct 21; 104(4):38. PubMed ID: 9793554
    [No Abstract] [Full Text] [Related]

  • 12. FDA, Roche to implement new dispensing procedures for isotretinoin.
    Young D.
    Am J Health Syst Pharm; 2001 Dec 15; 58(24):2359-60. PubMed ID: 11794946
    [No Abstract] [Full Text] [Related]

  • 13. Acute hip monoarthritis in a patient treated with isotretinoin.
    Pedraz T, Martínez A, Pascual E.
    J Clin Rheumatol; 2006 Apr 15; 12(2):105-6. PubMed ID: 16601552
    [No Abstract] [Full Text] [Related]

  • 14. Utility of studying the ocular surface in patients with acne vulgaris treated with oral isotretinoin: a randomized controlled trial.
    Aragona P, Cannavò SP, Borgia F, Guarneri F.
    Br J Dermatol; 2005 Mar 15; 152(3):576-8. PubMed ID: 15787837
    [No Abstract] [Full Text] [Related]

  • 15. New warnings on the use of isotretinoin (Roaccutane).
    Gunston G, Mehta U, van de Wal B.
    S Afr Med J; 1998 Nov 15; 88(11):1394. PubMed ID: 9861942
    [No Abstract] [Full Text] [Related]

  • 16. Roche responds to 'new warnings on the use of isotretinoin (Roaccutane)'.
    Ebrahim O, Bredenhann M.
    S Afr Med J; 1999 Jan 15; 89(1):16. PubMed ID: 10070397
    [No Abstract] [Full Text] [Related]

  • 17. Isotretinoin-induced nail fragility and onycholysis.
    Onder M, Oztaş MO, Oztaş P.
    J Dermatolog Treat; 2001 Jun 15; 12(2):115-6. PubMed ID: 12243670
    [Abstract] [Full Text] [Related]

  • 18. Acute monoarthritis in a patient under isotretinoin.
    Dubourg G, Koeger AC, Huchet B, Rozenberg S, Bourgeois P.
    Rev Rhum Engl Ed; 1996 Mar 15; 63(3):228-9. PubMed ID: 8731245
    [No Abstract] [Full Text] [Related]

  • 19. [Probable acute hemorrhagic colitis caused by isotretinoin with a test of repeated administration].
    Deplaix P, Barthélémy C, Védrines P, Perrot JL, Lanthier K, Pignato F, Audigier JC.
    Gastroenterol Clin Biol; 1996 Feb 15; 20(1):113-4. PubMed ID: 8734319
    [No Abstract] [Full Text] [Related]

  • 20. Ethical and legal aspects of teratogenic medications: the case of isotretinoin.
    Moskop JC, Smith ML, De Ville K.
    J Clin Ethics; 1997 Feb 15; 8(3):264-78. PubMed ID: 9436085
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.